Business / Finance

RSS

Regulatory, commercial considerations are the primary drivers for biosimilar development

Regulatory and commercial considerations are the primary drivers for successful biosimilar clinical development, according to a new report from Quintiles, titled An Integrated Approach to Biosimilar Development & Commercialization. In addition, the report states that successful biosimilar companies will be those who collapse their clinical, commercial, and regulatory thinking into a streamlined cohesive function as they proceed with developing biosimilars.

1 Oct 2011

CCS Medical moves corporate headquarters to Farmers Branch, Texas

CCS Medical today announced the relocation of their corporate headquarters from Clearwater, Florida to Farmers Branch, Texas in the Dallas-Fort Worth Metroplex. CCS Medical has more than 1,500 employees in seven offices across the nation, and is a market leader in distributing home healthcare products and services to patients with chronic conditions in the United States.

1 Oct 2011

QHR announces 1,000,000 stock options to various directors and employees

QHR Technologies Inc. announced today that it has granted an aggregate of 1,000,000 stock options to various directors, employees and consultants of the Company.

1 Oct 2011

Nightingale retains Questrade to provide market making services

Nightingale Informatix Corporation, an application service provider (ASP) of electronic medical record (EMR) software and related services today announced that it has retained Questrade Inc. to provide market making services. The market making service will be undertaken by Questrade in compliance with the guidelines of the TSX Venture Exchange.

1 Oct 2011

Concord Medical Services Holdings' directors approve share repurchase program

Concord Medical Services Holdings Limited, the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its board of directors approved a share repurchase program, effective immediately.

1 Oct 2011

MDC Partners acquires majority stake in Concentric Pharma

Concentric Pharma Advertising, one of the largest and fastest-growing healthcare advertising agencies in the country, announced today that MDC Partners, Inc., has acquired a majority stake in the company.

1 Oct 2011

TerraMedica changes company name to Fortel Analytics

Effective today, TerraMedica has changed its name to Fortel Analytics to reflect their focus on managing healthcare fraud and abuse prevention through advancing new and innovative predictive solutions, analysis methods and analytical technology.

1 Oct 2011

AxoGen mergers with LecTec

AxoGen, Inc., the parent company of AxoGen Corporation, has announced completion of the merger between LecTec Corporation and AxoGen Corporation.

1 Oct 2011

Health Management acquires assets of Mercy Health Partners

Health Management Associates, Inc. today announced that a subsidiary of Health Management has completed its acquisition of the assets of Mercy Health Partners, which is a subsidiary of Catholic Health Partners, Inc.

1 Oct 2011

General Dynamics acquires Vangent

General Dynamics today completed its acquisition of Vangent Holding Corp., the parent company of Vangent, Inc., a leading provider of healthcare information technology and business systems to federal agencies.

1 Oct 2011

Takeda acquires Nycomed

Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current role as Executive Vice President (EVP), International Operations, Takeda Pharmaceuticals International, Inc., a wholly owned subsidiary of Takeda America Holdings, Inc.

30 Sep 2011

Study highlights importance of prior planning before introduction of new vaccines

Proper planning before the introduction of new vaccines into a developing country's active immunization program could prevent storage problems and transportation bottlenecks that decrease the availability of existing vaccines by as much as two-thirds, according to a University of Pittsburgh study.

30 Sep 2011

G-Zero receives NIAID's Phase II Small Business Innovation Research Grant

G-Zero Therapeutics, an RTP company started in 2008 based on technologies from the University of North Carolina at Chapel Hill, has been awarded a $3 million Phase II Small Business Innovation Research Grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.

30 Sep 2011

SIS becomes an Industry Supporter of ASA

Surgical Information Systems (SIS) has become an Industry Supporter of the American Society of Anesthesiologists (ASA), as a part of a Corporate Supporter program available to pharmaceutical, medical device, anesthesia information management system and practice management companies.

29 Sep 2011

Bone and joint health supplements market to be worth over $9 billion by 2017

A globally ageing population, changing consumer lifestyles and a focus on preventative medicine is driving growth in the bone and joint health supplements market, which is forecast to be worth over $9 billion by 2017.

29 Sep 2011

Merck sells 50% interest in JJMCP joint venture

Merck, known outside the United States and Canada as MSD, today announced that the company has sold its 50 percent interest in the Johnson & Johnson--Merck Consumer Pharmaceuticals Co. joint venture (JJMCP) to Johnson & Johnson (J&J) affiliates, McNEIL-PPC, Inc., McNEIL MMP, LLC, and Johnson & Johnson, Inc.

29 Sep 2011

Ethicon Endo-Surgery announces definitive agreement to acquire SterilMed

Ethicon Endo-Surgery, Inc. (EES), a global leader in the development of innovative medical devices for minimally invasive and open surgical procedures, today announced a definitive agreement to acquire privately-held SterilMed, Inc. (SterilMed), a leader in the reprocessing and remanufacturing of medical devices in the United States.

28 Sep 2011

Dynatronics fourth quarter sales increase 3% to $8,190,382

Dynatronics Corporation today announced results for its fiscal fourth quarter and year ended June 30, 2011.

28 Sep 2011

DJO receives exclusive rights to sell Exos' range of upper extremity products

DJO Global, Inc., a leading global provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that it has signed an exclusive distribution agreement with Exos Corporation, providing DJO with exclusive rights to sell Exos' broad range of upper extremity products that incorporate Exos' thermoformable polymer technology in North and South America.

28 Sep 2011

Lockheed Martin acquires QTC

Lockheed Martin Corporation has completed its acquisition of QTC Holdings Inc. The company, based in Diamond Bar, Calif., is the largest provider of outsourced medical evaluation services to the U.S. Department of Veterans Affairs (VA), processing more than 450,000 evaluations last year.

28 Sep 2011